Biomerieux France Chemin De L'Or recalls VIDAS NT-pro-BNP Product Usage: VIDAS¿ NTproBNP (PBNP) is an automated quantitative test for use on the instruments of…
- Recall date
- April 15, 2016
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-2779-2016
- FDA classification
- Class III
- Brand / firm
- Biomerieux France Chemin De L'Or
- Sold / distributed
- US Nationwide Distribution in the states of: AL, AZ, CA, FL, GA, IA, KS, KY, MA, MI, MN, NC, NE, NJ, NY, OH, SC, TX, VA and WV.
Why it was recalled
Due to a packaging error; The kit does not contain the correct number of C1 or C2 control vials.
Class III means the product violates regulations but is not likely to cause harm.
What was recalled
VIDAS NT-pro-BNP Product Usage: VIDAS¿ NTproBNP (PBNP) is an automated quantitative test for use on the instruments of the VIDAS family for the determination of N terminal fragment of Btype natriuretic peptide in human serum or plasma (lithium heparin) using the ELFA technique (EnzymeLinked Fluorescent Assay). The VIDAS NTproBNP (PBNP) test is used as an aid in the diagnosis of suspected congestive heart failure.
Get recall alerts
Free email alert whenever Biomerieux France Chemin De L'Or has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Biomerieux France Chemin De L'Or